@article{4af71f38c2434aea8637bb44d004dfed,
title = "Monitoring activity of fibrinolytic agents. A therapeutic challenge",
abstract = "The recognition that thrombolytic therapy may be beneficial for coronary thrombolysis has led to an increased use of plasminogen activators in critically ill patients, sometimes with inadequate monitoring. This review delineates the components of the fibrinolytic system, describes mechanisms of fibrinolysis, and presents practical guidelines for monitoring the use of activators of the system.",
author = "Shafer, {Kenneth E.} and Santoro, {Samuel A.} and Sobel, {Burton E.} and Jaffe, {Allan S.}",
note = "Funding Information: From the Cardiovascular Division and Division of Laboratory Medicine, Washington University School of Medicine, St. Louis, Missouri. This work was supported in part by Public Health Service Grant AL-29606 and SCOR in lschemic Heart Disease, and National Institutes of Health Grant HL-17646. Requests for reprints should be addressed to Dr. Allan S. Jaffe, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, Missouri 63110. Manuscript accepted May 24, 1983.",
year = "1984",
month = may,
doi = "10.1016/0002-9343(84)91003-9",
language = "English (US)",
volume = "76",
pages = "879--886",
journal = "The American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "5",
}